Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
Descriptor ID |
D015996
|
MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 12 | 12 | 1996 | 0 | 10 | 10 | 1997 | 0 | 25 | 25 | 1998 | 0 | 19 | 19 | 1999 | 0 | 16 | 16 | 2000 | 0 | 20 | 20 | 2001 | 0 | 19 | 19 | 2002 | 0 | 25 | 25 | 2003 | 0 | 19 | 19 | 2004 | 0 | 23 | 23 | 2005 | 0 | 36 | 36 | 2006 | 0 | 47 | 47 | 2007 | 0 | 42 | 42 | 2008 | 0 | 45 | 45 | 2009 | 0 | 48 | 48 | 2010 | 1 | 59 | 60 | 2011 | 0 | 59 | 59 | 2012 | 1 | 47 | 48 | 2013 | 0 | 68 | 68 | 2014 | 1 | 91 | 92 | 2015 | 0 | 72 | 72 | 2016 | 2 | 74 | 76 | 2017 | 2 | 90 | 92 | 2018 | 1 | 68 | 69 | 2019 | 0 | 90 | 90 | 2020 | 0 | 76 | 76 | 2021 | 0 | 47 | 47 | 2022 | 0 | 6 | 6 | 2023 | 0 | 7 | 7 | 2024 | 0 | 48 | 48 | 2025 | 0 | 12 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Maurer MS, Judge DP, Gillmore JD, Garcia-Pavia P, Masri A, Cappelli F, Alexander KM, Sarswat N, Grogan M, Ambardekar AV, Ducharme A, Poulsen SH, Lam K, Obici L, Soman P, Rao S, Tamby JF, Casta?o A, Fox JC, Adam B, Chepyala SR, Poland B, Sinha U, Fontana M. Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.
-
Karol SE, Khaw SL, Zwaan CM, Baruchel A, Bittencourt H, Cooper TM, Flotho C, Fraser C, Forlenza CJ, Goldsmith KC, Macy ME, Morgenstern DA, O'Brien MM, Petit A, Ziegler DS, Reinhardt D, Opferman JT, Rubnitz JE, Onishi M, Dunshee DR, Dunbar F, Vishwamitra D, Ross JA, Chen X, Unnebrink K, Kammerlander M, Salem AH, Palenski TL, Sunkersett G, Place AE. Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia. Pediatr Blood Cancer. 2025 Jul; 72(7):e31714.
-
Acker SN, Ziogas IA, Cost N, Cooper E, Farooqui Z, Eason CR, Vaughn AE, Dawson-Gore C, Somers KM, Fineman SL, Vangi S, Carter MM, Hartman SJ, Kotagal M. Association of Systemic Inflammatory Markers and Clinical Outcomes Among Children With Wilms Tumor. Pediatr Blood Cancer. 2025 Jul; 72(7):e31715.
-
Aye JM, Xue W, Gao Z, Ladra M, Indelicato DJ, Sheyn A, Dasgupta R, Arnold MA, Shenoy A, Linardic CM, Venkatramani R. Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2025 Jun; 72(6):e31673.
-
Valverde P, Velasquez T, Ortiz R, Fuentes-Alabi SL, Pe?a A, Gonzalez JF, Gutierrez TL, Melendez LE, Tome E, Arreola M, Valsecchi MG, Colombo V, Luna-Fineman S, Blanco-Lopez J, Metzger ML, Spreafico F. Challenges and Opportunities of a Multi-Institutional Treatment Guideline for Wilms Tumor in Low-Middle-Income Countries-A Report From the Asociaci?n de Hemato-Oncolog?a Pedi?trica de Centro Am?rica (AHOPCA). Pediatr Blood Cancer. 2025 May; 72(5):e31616.
-
Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F, Shen F, Maithel S, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Marques H, Groot Koerkamp B, Endo I, Pawlik TM. The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2025 Jun; 32(6):4341-4351.
-
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Impact of disparity between imaging and pathological tumor size on cancer-specific prognosis among patients with hepatocellular carcinoma. Eur J Surg Oncol. 2025 Jun; 51(6):109683.
-
Rompen IF, Stoop TF, van Roessel S, van Veldhuisen E, Janssen QP, Alseidi A, Balduzzi A, Balzano G, Berrevoet F, Bonds M, Busch OR, Butturini G, Javed AA, Del Chiaro M, Conlon KC, Falconi M, Frigerio I, Fusai GK, Gagni?re J, Griffin O, Hackert T, Sparrelid E, Halimi A, Labori KJ, Malleo G, Marino MV, Mortensen MB, Nikov A, Lesurtel M, Keck T, Kleeff J, Pand? R, Pfeiffer P, Pietrasz D, Roberts KJ, Sa Cunha A, Salvia R, Strobel O, Tarvainen T, van Laarhoven HWM, Groot Koerkamp B, Loos M, Michalski CW, Besselink MG, Hank T. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
-
Kawashima J, Akabane M, Endo Y, Woldesenbet S, Khalil M, Sahara K, Ruzzenente A, Aldrighetti L, Bauer TW, Marques HP, Lopes R, Oliveira S, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Sasaki K, Maithel SK, Hugh T, Gleisner A, Aucejo F, Pulitano C, Shen F, Cauchy F, Groot Koerkamp B, Endo I, Pawlik TM. A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size. Ann Surg Oncol. 2025 May; 32(5):3505-3515.
-
Woodard GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, David EA, Jacobs JP, Kosinski AS, Blasberg JD, Boffa DJ. Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation. Ann Thorac Surg. 2025 May; 119(5):1071-1081.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|